The Wisconsin Biohealth Summit is a highly anticipated event that brings together innovators, researchers, investors, and industry leaders in the biohealth sector. This year, on October 17, 2023, the Summit promises to be an even more remarkable experience for attendees as it showcases the groundbreaking work and statewide industry commitment to personalized medicine. Hosted at the stunning Overture Center for the Arts, the Summit offers a platform to explore the cutting-edge solutions and promising future of Wisconsin’s thriving biohealth industry.
One of the most eagerly awaited segments of the Wisconsin Biohealth Summit is the Emerging Growth Company Panel. This panel has always been an attendee favorite, showcasing the latest advancements, trends, and insights within the industry. However, this year’s panel holds even greater excitement, as all the participating companies share a common commitment to personalized medicine. Personalized medicine, a rapidly evolving field, tailors medical treatments to the individual characteristics of each patient, leading to more effective outcomes and improved patient care.
Diverse and Accomplished Speakers
The panel is moderated by Jill Enos, a Managing Director at Titletown Tech, with a wealth of experience in early-stage ventures and innovation. Jill has played a pivotal role in creating and spinning out new ventures and capabilities for Fortune 50 innovation leaders.
John Reimer, known as the “Baseball Buddha,” serves as the VP of Business Development at Xiogenix. With nearly two decades of experience in the medical supply and bioscience sectors, John has been instrumental in driving Xiogenix’s innovative advancements in Cell & Gene Therapy and Tissue Banking.
Dr. Indrajit Choudhuri, Founder & CEO of Medicardia Health, brings over 15 years of expertise in cardiovascular clinical operations, value-based care, and population health. His background in electrical engineering and cardiovascular informatics adds a unique perspective to the panel’s discussions.
Khalid K. Alam, Ph.D., Founder & CEO of Stemloop, represents the synthetic biology space. His startup, Stemloop, is unlocking the potential of biological sensors to revolutionize various applications. With a Ph.D. in Biochemistry and a focus on innovation and entrepreneurship, Khalid is driving impactful changes in the field.
Dr. Julie Tetzlaff, COO of DivergeTSL, is dedicated to advancing research on critical issues like Sudden Infant Death Syndrome. Her collaboration with the Pediatric Pathology Department and other stakeholders showcases the importance of interdisciplinary efforts in healthcare innovation.
Lara Riem, Ph.D., Director of AI & Data Science at Springbok Analytics, brings expertise in biomechanics and data science to the panel. As a registered patent agent, Lara is uniquely positioned to discuss the intersection of AI, data science, and intellectual property protection.
A Glimpse into the Future
The Emerging Growth Company Panel at the Wisconsin Biohealth Summit 2023 promises to be an engaging and enlightening experience for attendees. By highlighting companies dedicated to personalized medicine, the panel underscores the transformative potential of tailoring medical approaches to individual patient needs. These innovators are shaping the future of healthcare, where treatments are no longer one-size-fits-all but are customized for maximum effectiveness.
As attendees witness the exciting evolution of personalized medicine in Wisconsin, they will gain insights into the dynamic synergy between technology, healthcare, and innovation. The panel’s diverse perspectives, ranging from clinical operations to synthetic biology and data science, provide a comprehensive view of the biohealth landscape and the exciting possibilities that lie ahead.
The future of healthcare is personalized, and the Wisconsin Biohealth Summit is the place to witness its exciting evolution. Attend the Summit to learn more!
